Systematic review of health economic models for assessment and diagnosis of dementia
Authors:
- Joseph KwonJKJoseph Kwon
- Lisanne SchoutensLSLisanne Schoutens
- Mitchell BurdenMBMitchell Burden
- Charlotte ColamCCCharlotte Colam
- Behrouz Nezafat MaldonadoBMBehrouz Nezafat Maldonado
- Elizabeth BlundellEBElizabeth Blundell
- Anastasia KrywonosAKAnastasia Krywonos
- Jingjing JiangJJJingjing Jiang
- Maria KaragiannidouMKMaria Karagiannidou
- Christoph JindraCJChristoph Jindra
- Nemanja VaciNVNemanja Vaci
Open Access
- 9 July 2025
- journal article
- review article
- Published by Wiley in Alzheimer's & Dementia: Behavior & Socioeconomics of Aging
- Vol. 1 (3)
Abstract
INTRODUCTION: Timely diagnosis of dementia is a public health priority to enable risk modification and treatment access. This study systematically identifies and critically appraises health economic models of dementia assessment and diagnosis.METHODS: Inclusion criteria were: any dementia stage; evaluated strategy(ies) for initial assessment/diagnosis of dementia; health economic evaluation using decision modeling. Ten databases were searched for 2000–2024. Philips checklist was applied for quality assessment. Narrative synthesis appraised methodological features and issued decision‐making recommendations.RESULTS: Thirty‐two studies were included. Six evaluated cerebrospinal fluid (CSF); 11 neuroimaging including amyloid‐targeting positron emission tomography; three blood‐based biomarkers; two genetic testing; and 10 early assessment/diagnosis strategies. Methodological limitations included non‐consideration of capacity constraints. Decision‐making recommendations generally affirmed current clinical guidelines: for example, CSF to confirm Alzheimer's disease is cost‐effective (incremental cost‐effectiveness ratio of £10,150 per quality‐adjusted life‐year gained vs. no use).DISCUSSION: Methodological appraisal and decision‐making recommendations should assist model development and evidence‐based dementia diagnosis.Keywords
Funding Information
- National Institute for Health and Care Research (ACF‐2020‐21‐011)
- Invention for Innovation Programme (NIHR202146)
- National Institute for Health and Care Research Applied Research Collaboration Oxford and Thames Valley
This publication has 87 references indexed in Scilit:
- 2023 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2023
- Cost‐effectiveness models for Alzheimer's disease and related dementias: IPECAD modeling workshop cross‐comparison challengeAlzheimer's & Dementia, 2022
- Preparedness of the Brazilian health‐care system to provide access to a disease‐modifying Alzheimer's disease treatmentAlzheimer's & Dementia, 2022
- Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid StatusJAMA Neurology, 2019
- Cost effectiveness of using cognitive screening tests for detecting dementia and mild cognitive impairment in primary careInternational Journal of Geriatric Psychiatry, 2016
- Exploring the cost‐effectiveness of a one‐off screen for dementia (for people aged 75 years in England and Wales)International Journal of Geriatric Psychiatry, 2014
- Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the BrainArchives of Neurology, 2009
- Clinical and cost effectiveness of services for early diagnosis and intervention in dementiaInternational Journal of Geriatric Psychiatry, 2009
- Dementia Screening in Primary CareJAMA, 2007
- What constitutes health‐related quality of life in dementia? Development of a conceptual framework for people with dementia and their carersInternational Journal of Geriatric Psychiatry, 2005